RxDoctor Payments DataLook up a doctor →

Barbara Burton

Clinical Genetics (M.D.) · Chicago, ILNPI 1699743088

Payments from drug & device makers

$6,485,648in general payments, 2019–2025

Across 1,236 payments — averaging $5247.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$3.5M
  • Biomarin Pharmaceutical Inc.$958K
  • Shire North American Group Inc$940K
  • Ultragenyx Pharmaceutical Inc.$687K
  • AstraZeneca$89K
  • Amgen$88K
  • plus $267K from 20 others
$12,932in research payments, 2019–2025

Across 15 payments — averaging $862.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$5K
  • Biomarin Pharmaceutical Inc.$4K
  • Modernatx, Inc.$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few clinical genetics (m.d.) providers in Illinoisto place this figure against a meaningful peer group, so we don't.

Other clinical genetics (m.d.) in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →